Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free OXBRW Stock Alerts

Oxbridge Re (OXBRW) Financials

$0.14 +0.01 (+3.72%)
As of 07/20/2026 03:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Oxbridge Re

Annual Income Statements for Oxbridge Re

This table shows Oxbridge Re's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 4.00 4.60 2.58 -21 -5.75 -0.31 -0.10 -1.79 -9.92 -2.73 -2.08
Consolidated Net Income / (Loss)		 4.00 4.60 2.58 -21 -5.75 -0.31 -0.10 -1.79 -9.37 -2.59 -2.08
Net Income / (Loss) Continuing Operations		 4.00 4.60 2.58 -21 -7.75 -0.15 0.04 -1.75 -9.37 -2.59 -2.08
Total Pre-Tax Income 		4.00 4.60 2.58 -21 -7.75 -0.15 0.09 -1.75 -9.37 -2.59 -2.08
Total Revenue		 5.56 6.38 19 24 3.81 0.88 1.21 0.85 -7.05 0.55 2.58
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 5.56 6.38 19 24 3.81 0.88 1.16 0.85 -7.05 0.55 2.58
Other Service Charges		 - - - - - - - 0.00 0.30 0.31 0.00
Net Realized & Unrealized Capital Gains on Investments		 0.74 -0.39 1.00 0.27 1.11 0.23 0.43 0.19 -8.64 -1.81 0.33
Premiums Earned		 11 15 17 22 2.95 0.62 0.89 1.00 1.26 2.30 2.29
Other Non-Interest Income		 -5.77 -8.29 0.88 1.34 -0.25 0.03 -0.16 -0.34 0.04 -0.26 -0.04
Total Non-Interest Expense		 1.56 1.78 16 44 12 1.03 1.13 2.60 2.32 2.17 6.04
Property & Liability Insurance Claims		 - 0.00 15 42 10 - - 1.07 - 0.00 2.74
Insurance Policy Acquisition Costs		 0.43 0.34 0.29 0.68 0.26 0.06 0.10 0.11 0.14 0.25 0.25
Other Operating Expenses		 1.13 1.44 1.42 1.33 1.28 0.96 1.03 1.41 2.18 1.92 3.05
Nonoperating Income / (Expense), net		 - - - - - - - - - -0.96 1.39
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - - - 0.04 0.00 0.14 0.00
Basic Earnings per Share		 $0.82 $0.76 $0.43 ($3.55) ($1.00) ($0.05) ($0.01) ($0.31) ($1.69) ($0.45) ($0.28)
Weighted Average Basic Shares Outstanding		 4.86M 6.06M 6.02M 5.81M 5.73M 5.73M 5.73M 5.77M 5.87M 6.10M 7.39M
Diluted Earnings per Share		 $0.82 $0.76 $0.43 ($3.55) ($1.00) ($0.05) - ($0.31) ($1.69) ($0.45) ($0.28)
Weighted Average Diluted Shares Outstanding		 4.86M 6.06M 6.02M 5.81M 5.73M 5.73M 5.73M 5.77M 5.87M 6.10M 7.39M
Weighted Average Basic & Diluted Shares Outstanding		 4.86M 6.06M 6.02M 5.81M 5.73M 5.73M 5.73M 5.87M 5.87M 7.44M 7.80M

Quarterly Income Statements for Oxbridge Re

This table shows Oxbridge Re's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -7.30 -2.67 -0.91 -0.82 -0.54 -0.46 -0.14 -1.87 -0.19 0.12 0.02
Consolidated Net Income / (Loss)		 -7.30 -2.13 -0.91 -0.82 -0.54 -0.32 -0.13 -2.00 -0.17 0.22 0.04
Net Income / (Loss) Continuing Operations		 -7.07 -2.44 -0.91 -0.82 -0.54 -0.32 -0.13 -2.00 -0.17 0.22 0.04
Total Pre-Tax Income 		-7.07 -2.44 -0.91 -0.82 -0.54 -0.32 -0.13 -2.00 -0.17 0.22 0.04
Total Revenue		 -6.38 -1.91 -0.13 0.04 0.21 0.42 0.69 0.66 0.65 0.58 0.62
Net Interest Income / (Expense)		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Non-Interest Income		 -6.38 -1.91 -0.13 0.04 0.21 0.42 0.69 0.66 0.65 0.58 0.62
Net Realized & Unrealized Capital Gains on Investments		 -6.82 -2.50 -0.59 -0.76 -0.36 -0.10 0.09 0.09 0.08 0.06 0.07
Premiums Earned		 0.55 0.52 0.55 0.56 0.60 0.60 0.60 0.58 0.56 0.56 0.56
Other Non-Interest Income		 -0.12 0.07 -0.09 -0.07 -0.03 -0.07 0.00 -0.01 0.01 -0.04 0.00
Total Non-Interest Expense		 0.69 0.54 0.78 0.63 0.50 0.27 0.82 3.61 0.82 0.79 0.59
Insurance Policy Acquisition Costs		 0.06 0.06 0.06 0.06 0.07 0.07 0.07 0.06 0.06 0.06 0.06
Other Operating Expenses		 0.63 0.47 0.49 0.57 0.43 0.43 0.51 1.26 0.75 0.53 0.52
Other Special Charges		 - - 0.23 - - - 0.25 - - - 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.23 -0.31 0.00 0.00 0.00 0.14 0.01 -0.13 0.02 0.10 0.02
Basic Earnings per Share		 ($1.24) ($0.46) ($0.15) ($0.14) ($0.09) ($0.07) ($0.02) ($0.25) ($0.02) $0.01 $0.00
Weighted Average Basic Shares Outstanding		 5.87M 5.87M 6.01M 6.01M 6.12M 6.10M 6.90M 7.44M 7.66M 7.39M 7.80M
Diluted Earnings per Share		 ($1.24) ($0.46) ($0.15) ($0.14) ($0.09) ($0.07) ($0.02) ($0.25) ($0.02) $0.01 $0.00
Weighted Average Diluted Shares Outstanding		 5.87M 5.87M 6.01M 6.01M 6.12M 6.10M 6.90M 7.44M 7.66M 7.39M 7.80M
Weighted Average Basic & Diluted Shares Outstanding		 - 5.87M 6.01M 6.04M 6.23M 7.44M 7.44M 7.54M 7.68M 7.80M 8.10M

Annual Cash Flow Statements for Oxbridge Re

This table details how cash moves in and out of Oxbridge Re's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 4.62 3.27 3.66 -25 0.41 -3.28 -0.44 -1.49 -0.18 2.15 1.08
Net Cash From Operating Activities		 8.68 8.13 0.37 -26 -6.63 -4.37 -0.27 -0.83 -1.26 -0.28 -1.35
Net Cash From Continuing Operating Activities		 8.68 8.13 0.42 -26 -6.63 -4.37 -0.17 -0.83 -1.26 -0.28 -1.35
Net Income / (Loss) Continuing Operations		 4.00 4.60 2.58 -21 -5.75 -0.31 0.05 -1.79 -9.92 -2.73 -2.08
Consolidated Net Income / (Loss)		 4.00 4.60 2.58 -21 -5.75 -0.31 0.05 -1.79 -9.92 -2.73 -2.08
Depreciation Expense		 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.00 0.01 0.00 0.00
Non-Cash Adjustments to Reconcile Net Income		 -0.22 0.84 -0.44 0.65 -1.98 0.01 -0.19 0.47 8.87 2.38 0.44
Changes in Operating Assets and Liabilities, net		 4.89 2.67 -1.77 -6.48 1.07 -4.08 -0.04 0.48 -0.22 0.06 0.29
Net Cash From Investing Activities		 -29 -1.95 6.87 4.67 5.05 0.49 0.11 -0.66 -0.11 0.78 0.12
Net Cash From Continuing Investing Activities		 -29 -1.95 6.87 4.67 5.05 0.49 0.11 -0.66 -0.11 0.78 0.12
Purchase of Property, Leasehold Improvements and Equipment		 -0.06 -0.04 -0.01 -0.01 0.00 -0.00 -0.01 0.00 -0.01 0.00 -0.02
Sale and/or Maturity of Investments		 8.01 13 20 27 16 0.99 2.72 0.63 0.00 0.78 0.14
Net Cash From Financing Activities		 25 -2.91 -3.63 -3.15 2.00 0.60 -0.38 0.00 1.18 1.65 2.31
Net Cash From Continuing Financing Activities		 25 -2.91 -3.63 -3.15 2.00 0.60 -0.38 0.00 1.18 1.65 2.31
Issuance of Debt		 - - - 0.00 2.00 0.60 0.22 0.00 1.28 1.47 0.00
Issuance of Common Equity		 0.01 - - - - - - - 0.00 1.13 3.53
Other Financing Activities, Net		 27 - - - - - -0.00 - - -0.95 -1.21

Quarterly Cash Flow Statements for Oxbridge Re

This table details how cash moves in and out of Oxbridge Re's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 0.16 0.10 0.57 -0.33 0.84 1.07 3.70 -2.94 0.52 -0.20 1.21
Net Cash From Operating Activities		 0.26 0.10 -0.28 -0.04 0.26 -0.23 0.27 -2.17 0.12 0.43 0.21
Net Cash From Continuing Operating Activities		 0.26 0.10 -0.28 -0.04 0.26 -0.23 0.27 -2.17 0.12 0.43 0.21
Net Income / (Loss) Continuing Operations		 -7.30 -2.67 -0.91 -0.82 -0.54 -0.46 -0.14 -1.87 -0.19 0.12 0.02
Consolidated Net Income / (Loss)		 -7.30 -2.67 -0.91 -0.82 -0.54 -0.46 -0.14 -1.87 -0.19 0.12 0.02
Depreciation Expense		 0.00 0.00 0.00 - 0.00 - 0.00 - - 0.00 0.00
Non-Cash Adjustments to Reconcile Net Income		 7.10 2.55 0.80 0.63 0.52 0.43 0.13 0.00 0.18 0.15 0.06
Changes in Operating Assets and Liabilities, net		 0.46 0.22 -0.17 0.16 0.27 -0.20 0.28 -0.30 0.12 0.16 0.13
Net Cash From Investing Activities		 -0.10 - 0.45 - - 0.33 0.06 - - 0.06 0.00
Net Cash From Continuing Investing Activities		 -0.10 - 0.45 - - 0.33 0.06 - - 0.06 0.00
Sale and/or Maturity of Investments		 - - 0.45 -0.14 - 0.47 0.06 - - 0.07 0.00
Net Cash From Financing Activities		 0.00 - 0.40 -0.29 0.58 0.97 3.37 -0.77 0.41 -0.69 1.00
Net Cash From Continuing Financing Activities		 0.00 - 0.40 -0.29 0.58 0.97 3.37 -0.77 0.41 -0.69 1.00
Issuance of Debt		 - - 0.40 1.07 - - 3.12 -0.25 - - 1.00
Other Financing Activities, Net		 - - - - - - 0.25 - - - 0.00

Annual Balance Sheets for Oxbridge Re

This table presents Oxbridge Re's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 50 53 51 21 13 9.50 9.08 17 8.25 7.47 8.05
Cash and Due from Banks		 5.32 8.58 12 7.76 8.07 5.96 5.56 1.21 0.50 2.14 0.27
Restricted Cash		 28 30 23 3.12 3.23 2.05 1.91 2.72 3.25 3.76 6.71
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 0.05 0.06 0.05 0.04 0.02 0.01 0.01 0.01 0.00 0.00 0.02
Unearned Premiums Asset		 4.08 4.12 4.04 3.80 0.00 0.51 0.46 0.28 0.98 1.06 0.77
Deferred Acquisition Cost		 0.13 0.09 0.09 0.05 0.00 0.05 0.05 0.13 0.10 0.11 0.10
Other Assets		 0.08 0.09 0.10 0.12 0.07 0.21 0.30 12 2.68 0.29 0.19
Total Liabilities & Shareholders' Equity		 50 53 51 21 13 9.50 9.08 17 8.25 7.47 8.05
Total Liabilities		 13 16 14 7.48 4.25 1.45 1.06 1.63 2.92 1.62 1.56
Short-Term Debt		 - - - - - - - - - - 0.12
Long-Term Debt		 - - - - 0.00 0.60 0.22 0.22 0.12 0.12 0.00
Claims and Claim Expense		 - 0.00 8.70 4.84 4.11 - - 1.07 - 0.00 0.09
Unearned Premiums Liability		 5.74 5.57 3.46 2.01 0.00 0.44 0.41 0.00 0.92 0.99 0.93
Other Long-Term Liabilities		 7.24 10 1.67 0.63 0.14 0.41 0.43 0.34 1.89 0.51 0.43
Redeemable Noncontrolling Interest		 - - - - - - - - - 1.73 0.52
Total Equity & Noncontrolling Interests		 37 37 37 14 8.31 8.04 8.03 15 5.33 4.11 5.98
Total Preferred & Common Equity		 37 37 37 14 8.31 8.04 8.03 15 5.33 3.95 5.92
Total Common Equity		 37 37 37 14 8.31 8.04 8.03 15 5.33 3.95 5.92
Common Stock		 34 34 33 32 32 32 32 32 33 34 38
Retained Earnings		 3.15 4.84 4.53 -18 -24 -24 -24 -17 -27 -30 -32
Noncontrolling Interest		 - - - - - - - - 0.00 0.16 0.06

Quarterly Balance Sheets for Oxbridge Re

This table presents Oxbridge Re's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 7.26 7.82 7.32 10 9.17 8.85 8.74
Cash and Due from Banks		 0.53 3.59 1.41 4.96 3.87 0.73 0.89
Restricted Cash		 3.78 0.39 3.41 4.63 2.78 6.45 7.30
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 0.00 0.00 0.00 0.00 0.00 0.00 0.02
Unearned Premiums Asset		 0.49 2.12 1.37 0.22 1.98 1.21 0.23
Deferred Acquisition Cost		 0.05 0.24 0.18 0.04 0.22 0.16 0.04
Other Assets		 2.06 1.20 0.71 0.28 0.21 0.19 0.26
Total Liabilities & Shareholders' Equity		 7.26 7.82 7.32 10 9.17 8.85 8.74
Total Liabilities		 2.76 4.04 3.67 1.07 2.69 1.98 2.12
Short-Term Debt		 - - - - - - 0.12
Long-Term Debt		 0.12 0.12 0.12 0.12 0.12 0.12 1.00
Claims and Claim Expense		 - - - - 0.18 0.00 0.09
Unearned Premiums Liability		 0.37 2.18 1.59 0.40 2.04 1.48 0.37
Other Long-Term Liabilities		 2.28 1.74 1.97 0.55 0.36 0.38 0.54
Redeemable Noncontrolling Interest		 - - - 1.98 1.21 1.21 0.52
Total Equity & Noncontrolling Interests		 4.50 3.79 3.65 7.22 5.28 5.67 6.10
Total Preferred & Common Equity		 4.50 3.79 3.65 7.04 5.34 5.71 6.02
Total Common Equity		 4.50 3.79 3.65 7.04 5.34 5.71 6.02
Common Stock		 33 33 33 37 37 38 38
Retained Earnings		 -28 -29 -30 -30 -32 -32 -32
Noncontrolling Interest		 - - - 0.18 -0.06 -0.04 0.08

Annual Metrics And Ratios for Oxbridge Re

This table displays calculated financial ratios and metrics derived from Oxbridge Re's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 6,000,000.00 6,060,000.00 5,960,324.00 5,733,587.00 5,733,587.00 5,733,587.00 5,733,587.00 5,781,587.00 5,870,234.00 6,226,259.00 7,676,122.00
DEI Adjusted Shares Outstanding		 6,000,000.00 6,060,000.00 5,960,324.00 5,733,587.00 5,733,587.00 5,733,587.00 5,733,587.00 5,781,587.00 5,870,234.00 6,226,259.00 7,676,122.00
DEI Earnings Per Adjusted Shares Outstanding		 0.67 0.76 0.43 -3.59 -1.00 -0.05 -0.02 -0.31 -1.60 -0.42 -0.27
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 14.77% 198.78% 25.07% -84.02% -77.03% 38.74% 0.00% -929.29% 107.75% 371.98%
EBITDA Growth		 0.00% 15.10% -43.21% -880.94% 62.33% 98.19% 170.00% 0.00% -437.72% 82.68% -113.44%
EBIT Growth		 0.00% 15.03% -43.90% -897.83% 62.41% 98.06% 158.67% 0.00% -436.83% 82.66% -113.11%
NOPAT Growth		 0.00% 15.03% -43.90% -658.48% 62.37% 98.06% 183.81% 0.00% -436.83% 82.66% -113.11%
Net Income Growth		 0.00% 15.03% -43.90% -897.83% 72.08% 94.69% 67.21% 0.00% -423.92% 72.40% 19.64%
EPS Growth		 0.00% -7.32% -43.42% -925.58% 71.83% 95.00% 0.00% 0.00% -445.16% 73.37% 37.78%
Operating Cash Flow Growth		 0.00% -6.37% -95.40% -7,134.76% 74.79% 34.10% 93.91% 0.00% -51.99% 77.46% -374.65%
Free Cash Flow Firm Growth		 0.00% 0.00% -42.90% 261.17% -97.97% -341.51% 212.90% 0.00% 0.00% -151.58% -86.65%
Invested Capital Growth		 0.00% 0.87% 0.37% -62.55% -40.26% 3.96% -4.65% 0.00% -64.16% 9.36% 10.92%
Revenue Q/Q Growth		 0.00% -16.85% 135.45% -32.76% 65.08% -61.86% 19.37% 0.00% -71.88% 130.66% 6.36%
EBITDA Q/Q Growth		 0.00% -22.17% -50.44% 10.08% -852.05% 98.45% 653.85% 0.00% -49.92% 61.55% -12.11%
EBIT Q/Q Growth		 0.00% -22.27% -51.03% 10.02% -891.51% 98.34% 2,833.33% 0.00% -49.87% 61.51% -12.14%
NOPAT Q/Q Growth		 0.00% -22.27% -51.03% 10.02% -654.63% 98.34% 2,833.33% 0.00% -49.87% 65.47% -108.61%
Net Income Q/Q Growth		 0.00% -22.27% -51.04% 10.03% -942.96% 95.53% 41.18% 0.00% -42.77% 41.15% -25.24%
EPS Q/Q Growth		 0.00% -16.48% -51.14% 9.90% -869.23% 95.80% 0.00% 0.00% 0.00% 46.43% 22.22%
Operating Cash Flow Q/Q Growth		 0.00% 6.89% -89.69% -646.38% 74.33% 50.65% -26.67% 0.00% 16.17% -760.47% 54.46%
Free Cash Flow Firm Q/Q Growth		 0.00% -14.26% 74.15% -16.14% 109.88% -123.78% -6.67% -100.00% -68.43% 76.67% 29.87%
Invested Capital Q/Q Growth		 2.89% 1.16% -8.17% -0.01% -50.26% 0.82% 2.36% 4.89% 0.00% 58.13% -5.45%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 72.19% 72.40% 13.76% -85.92% -202.52% -16.00% 8.07% -204.94% 0.00% -297.07% -134.34%
EBIT Margin		 71.96% 72.12% 13.54% -86.37% -203.18% -17.14% 7.25% -205.41% 0.00% -297.62% -134.38%
Profit (Net Income) Margin		 71.96% 72.12% 13.54% -86.37% -150.89% -34.86% -8.24% -210.47% 0.00% -473.81% -80.68%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 74.19% 203.33% -113.64% 102.46% 100.00% 100.00% 100.10%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.10% 100.00% 100.00% 100.00% 100.00% 159.20% 59.98%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 10.90% 12.48% 6.96% -56.44% -48.80% -1.24% 1.04% -8.04% 0.00% -19.94% -38.57%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% -67.91% -45.04% -270.45% 0.00% -1,248.33% 253.89%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% -2.49% -2.29% -3.90% 0.00% -26.37% 4.86%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% 0.00% -3.73% -1.24% -11.94% -92.25% -46.30% -33.71%
Cash Return on Invested Capital (CROIC)		 0.00% 11.61% 6.59% 34.57% 1.62% -5.12% 5.80% 0.00% 30.93% -28.88% -48.92%
Operating Return on Assets (OROA)		 13.10% 8.99% 4.98% -56.89% -45.60% -1.36% 0.95% -10.51% 0.00% -20.68% -44.63%
Return on Assets (ROA)		 13.10% 8.99% 4.98% -56.89% -33.86% -2.77% -1.08% -10.77% 0.00% -32.92% -26.79%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% 0.00% -3.73% -1.24% -11.94% -92.25% -38.46% -26.96%
Return on Equity Simple (ROE_SIMPLE)		 10.90% 12.43% 6.95% -147.95% -69.15% -3.79% -1.25% -11.94% -175.79% -65.53% -35.14%
Net Operating Profit after Tax (NOPAT)		 4.00 4.60 2.58 -14 -5.42 -0.11 0.09 -1.22 -6.56 -1.14 -2.42
NOPAT Margin		 71.96% 72.12% 13.54% -60.46% -142.37% -12.00% 7.25% -143.79% 0.00% -208.33% -94.07%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 66.67% 46.08% 262.41% 1,683.77% 1,228.39% -292.46%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 28.04% 27.88% 86.46% 186.37% 303.18% 117.14% 92.75% 305.41% 0.00% 397.62% 234.38%
Earnings before Interest and Taxes (EBIT)		 4.00 4.60 2.58 -21 -7.74 -0.15 0.09 -1.75 -9.37 -1.63 -3.46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 4.01 4.62 2.62 -20 -7.72 -0.14 0.10 -1.74 -9.37 -1.62 -3.46
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.76 0.80 0.90 0.89 0.43 0.53 1.34 0.46 1.21 6.50 1.71
Price to Tangible Book Value (P/TBV)		 0.76 0.80 0.90 0.89 0.43 0.53 1.34 0.46 1.21 6.50 1.71
Price to Revenue (P/Rev)		 5.01 4.65 1.76 0.52 0.95 4.88 8.83 8.16 0.00 46.99 3.93
Price to Earnings (P/E)		 6.96 6.45 13.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 5.17% 9.80% 8.52% 22.33% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 14.37% 15.49% 7.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.10 0.00 0.00 0.42 0.21 0.52 3.65 0.58
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.06 0.00 0.00 2.85 3.80 0.00 39.88 1.49
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 35.32 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 39.34 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 39.34 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.16 0.00 0.00 7.06 0.00 0.89 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.07 0.03 0.01 0.02 0.02 0.02
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.07 0.03 0.01 0.02 0.02 0.00
Financial Leverage		 0.00 0.00 0.00 0.00 0.00 0.04 0.05 0.01 0.02 0.02 0.02
Leverage Ratio		 1.38 1.39 1.40 1.42 1.53 1.35 1.16 1.11 1.22 1.41 1.26
Compound Leverage Factor		 1.38 1.39 1.40 1.42 1.53 1.35 1.16 1.11 1.22 2.24 0.75
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 6.94% 2.62% 1.42% 2.17% 1.98% 1.78%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.78%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 6.94% 2.62% 1.42% 2.17% 1.98% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 31.78% 8.73%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 93.06% 97.38% 98.58% 97.83% 66.24% 89.49%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -4.29 2.20 -0.12 -0.01 -0.07 -0.03
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 52.97 -74.08 2.13 0.39 3.56 1.98
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -4.29 2.20 -0.12 -0.01 -0.07 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -5.71 2.45 -0.18 -0.02 -0.10 -0.05
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 70.63 -82.50 3.04 0.55 5.08 2.83
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -5.71 2.45 -0.18 -0.02 -0.10 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.95% 20.03%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 4.28 2.45 8.83 0.18 -0.43 0.49 0.00 3.19 -1.65 -3.08
Operating Cash Flow to CapEx		 14,710.17% 22,572.22% 3,400.00% -438,500.00% 0.00% -437,100.00% -1,900.00% 0.00% -25,200.00% 0.00% -8,425.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.18 0.12 0.37 0.66 0.22 0.08 0.13 0.05 0.00 0.07 0.33
Fixed Asset Turnover		 0.00 116.00 323.08 529.80 141.11 64.81 110.36 170.00 0.00 218.40 303.18
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 37 37 37 14 8.31 8.64 8.24 15 5.45 5.96 6.61
Invested Capital Turnover		 0.15 0.17 0.51 0.93 0.34 0.10 0.14 0.06 0.00 0.10 0.41
Increase / (Decrease) in Invested Capital		 0.00 0.32 0.14 -23 -5.60 0.33 -0.40 0.00 -9.76 0.51 0.65
Enterprise Value (EV)		 -5.65 -9.26 -2.10 1.44 -7.69 -3.14 3.46 3.23 2.83 22 3.85
Market Capitalization		 28 30 34 12 3.61 4.27 11 6.94 6.46 26 10
Book Value per Share		 $6.12 $6.11 $6.24 $2.43 $1.45 $1.40 $1.40 $2.59 $0.91 $0.63 $0.77
Tangible Book Value per Share		 $6.12 $6.11 $6.24 $2.43 $1.45 $1.40 $1.40 $2.59 $0.91 $0.63 $0.77
Total Capital		 37 37 37 14 8.31 8.64 8.24 15 5.45 5.96 6.61
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.60 0.22 0.22 0.12 0.12 0.12
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.60 0.22 0.22 0.12 0.12 0.00
Net Debt		 -33 -39 -36 -11 -11 -7.42 -7.26 -3.71 -3.63 -5.78 -6.86
Capital Expenditures (CapEx)		 0.06 0.04 0.01 0.01 0.00 0.00 0.01 0.00 0.01 0.00 0.02
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 6.18 0.32 0.20 0.19 0.57 2.81 1.45 -0.35
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 0.00 0.00 0.60 0.22 0.22 0.12 0.12 0.12
Total Depreciation and Amortization (D&A)		 0.01 0.02 0.04 0.11 0.03 0.01 0.01 0.00 0.01 0.00 0.00
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.82 $0.76 $0.43 ($3.55) ($1.00) ($0.05) ($0.01) $0.00 ($1.69) ($0.45) ($0.28)
Adjusted Weighted Average Basic Shares Outstanding		 6.06M 6.06M 5.89M 5.73M 5.73M 5.73M 5.73M 0.00 5.87M 6.10M 7.39M
Adjusted Diluted Earnings per Share		 $0.82 $0.76 $0.43 ($3.55) ($1.00) ($0.05) ($0.01) $0.00 ($1.69) ($0.45) ($0.28)
Adjusted Weighted Average Diluted Shares Outstanding		 6.06M 6.06M 5.89M 5.73M 5.73M 5.73M 5.73M 0.00 5.87M 6.10M 7.39M
Adjusted Basic & Diluted Earnings per Share		 $0.82 $0.76 $0.43 $0.00 $0.00 $0.00 ($0.01) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 4.86M 6.06M 5.89M 5.81M 5.73M 5.73M 5.73M 0.00 5.87M 7.44M 7.80M
Normalized Net Operating Profit after Tax (NOPAT)		 2.80 3.22 1.81 -14 -5.42 -0.11 0.06 -1.22 -6.56 -1.14 -2.42
Normalized NOPAT Margin		 50.37% 50.48% 9.48% -60.46% -142.37% -12.00% 5.07% -143.79% 0.00% -208.33% -94.07%
Pre Tax Income Margin		 71.96% 72.12% 13.54% -86.37% -203.39% -17.14% 7.25% -205.41% 0.00% -473.81% -80.60%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 42.70% 63.20% 111.78% -10.15% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 42.70% 63.20% 140.53% -15.31% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Oxbridge Re

This table displays calculated financial ratios and metrics derived from Oxbridge Re's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 5,870,234.00 5,870,234.00 5,870,234.00 6,006,661.00 6,036,579.00 6,226,259.00 7,442,922.00 7,442,922.00 7,535,922.00 7,676,122.00 7,801,374.00
DEI Adjusted Shares Outstanding		 5,870,234.00 5,870,234.00 5,870,234.00 6,006,661.00 6,036,579.00 6,226,259.00 7,442,922.00 7,442,922.00 7,535,922.00 7,676,122.00 7,801,374.00
DEI Earnings Per Adjusted Shares Outstanding		 -1.24 -0.36 -0.15 -0.14 -0.09 -0.05 -0.02 -0.27 -0.02 0.03 0.00
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -816.81% -282.65% -122.89% -93.63% 103.21% 122.15% 653.60% 1,409.09% 214.63% 36.49% -9.97%
EBITDA Growth		 -227.78% -458.68% -727.08% -11,580.00% 95.87% 106.44% 86.16% -405.14% 41.78% -238.22% 131.20%
EBIT Growth		 -227.72% -459.35% -737.32% -9,633.33% 95.86% 106.43% 86.19% -405.14% 41.98% -238.85% 130.40%
NOPAT Growth		 -227.72% -351.55% -546.13% -9,633.33% 95.86% 86.84% 86.19% -405.14% 41.98% 199.69% 143.43%
Net Income Growth		 -238.43% -414.16% -737.32% -865.88% 92.60% 84.93% 86.19% -144.09% 68.15% 169.16% 130.40%
EPS Growth		 0.00% 0.00% -850.00% -1,300.00% 92.74% 84.78% 86.67% -78.57% 77.78% 114.29% 100.00%
Operating Cash Flow Growth		 224.64% 165.31% -97.14% 97.63% 0.00% -340.63% 198.55% -6,102.86% -54.26% 287.45% -22.79%
Free Cash Flow Firm Growth		 1,426.25% 0.00% 679.22% 715.54% -141.62% -109.13% -147.32% -143.48% 15.91% 41.88% 133.81%
Invested Capital Growth		 0.00% -64.16% -69.94% -74.43% 0.00% 9.36% 101.69% 69.14% 85.51% 10.92% -16.96%
Revenue Q/Q Growth		 -1,023.44% 70.15% 93.44% 135.20% 365.91% 105.85% 63.98% -4.05% -2.86% -10.70% 8.16%
EBITDA Q/Q Growth		 -141,240.00% 65.49% 62.98% 35.33% 50.00% 153.77% -179.62% -2,260.00% 94.24% -27.65% 117.97%
EBIT Q/Q Growth		 -117,716.67% 65.48% 62.91% 35.47% 49.83% 153.58% -179.62% -2,260.00% 94.24% -28.24% 117.43%
NOPAT Q/Q Growth		 -117,716.67% 65.48% 62.91% 35.47% 49.83% -9.56% 61.06% -2,260.00% 94.24% 288.24% -83.04%
Net Income Q/Q Growth		 -8,488.24% 70.82% 57.51% 9.28% 34.23% 40.56% 61.06% -1,503.20% 91.42% 229.07% -82.88%
EPS Q/Q Growth		 -12,300.00% 62.90% 67.39% 6.67% 35.71% 22.22% 71.43% -1,150.00% 92.00% 150.00% -100.00%
Operating Cash Flow Q/Q Growth		 117.50% -62.79% -387.50% 87.32% 837.14% -189.53% 217.75% -898.16% 105.44% 266.95% -51.50%
Free Cash Flow Firm Q/Q Growth		 610.50% -15.72% 25.59% 8.44% -136.26% 81.51% -550.95% 0.37% 29.86% 87.22% 478.69%
Invested Capital Q/Q Growth		 -100.00% 0.00% -15.28% -15.42% -3.48% 58.13% 56.24% -29.07% 5.86% -5.45% 16.97%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 0.00% 0.00% 0.00% -1,327.27% -142.44% 37.20% -18.06% -444.28% -26.36% -37.67% 6.26%
EBIT Margin		 0.00% 0.00% 0.00% -1,327.27% -142.93% 37.20% -18.06% -444.28% -26.36% -37.85% 6.10%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% -1,865.91% -263.41% -76.07% -18.06% -301.81% -26.67% 38.54% 6.10%
Tax Burden Percent		 103.27% 87.30% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.11% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00% 140.58% 184.30% -204.46% 100.00% 67.93% 101.18% -102.75% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -5.10% -2.47% -117.36% -8.31% 15.94% 1.80%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% -86.71% -34.25% -65.66% -53.22% 14.25% 1.80%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% -1.83% -0.59% -1.51% -1.19% 0.27% 0.14%
Return on Equity (ROE)		 0.00% -92.25% -105.87% -117.79% -120.41% -6.93% -3.07% -118.86% -9.50% 16.22% 1.94%
Cash Return on Invested Capital (CROIC)		 0.00% 30.93% 34.50% 36.54% -374.81% -28.88% -85.58% -78.39% -81.50% -48.92% 2.81%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 2.58% -2.81% -103.68% -7.90% -12.57% 1.61%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% -5.28% -2.81% -70.43% -7.99% 12.80% 1.61%
Return on Common Equity (ROCE)		 0.00% -92.25% -105.87% -117.79% -120.41% -5.75% -2.58% -105.59% -8.45% 12.97% 1.60%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -231.61% -294.59% -120.41% 0.00% -25.67% -37.98% -29.07% 0.00% -31.83%
Net Operating Profit after Tax (NOPAT)		 -4.95 -1.71 -0.63 -0.41 -0.21 -0.22 -0.09 -2.07 -0.12 0.22 0.04
NOPAT Margin		 0.00% 0.00% 0.00% -929.09% -100.05% -53.25% -12.64% -310.99% -18.45% 38.89% 6.10%
Net Nonoperating Expense Percent (NNEP)		 0.00% 252.69% 187.24% 349.32% 567.63% 81.61% 31.78% -51.69% 44.92% 1.69% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 1,427.27% 242.93% 62.80% 118.06% 544.28% 126.36% 137.85% 93.90%
Earnings before Interest and Taxes (EBIT)		 -7.07 -2.44 -0.91 -0.58 -0.29 0.16 -0.13 -2.95 -0.17 -0.22 0.04
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -7.07 -2.44 -0.90 -0.58 -0.29 0.16 -0.13 -2.95 -0.17 -0.22 0.04
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 1.21 1.38 3.78 4.60 6.50 2.00 2.43 2.36 1.71 1.53
Price to Tangible Book Value (P/TBV)		 0.00 1.21 1.38 3.78 4.60 6.50 2.00 2.43 2.36 1.71 1.53
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 46.99 10.32 6.53 5.57 3.93 3.67
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.52 0.44 2.67 3.20 3.65 0.72 1.15 1.09 0.58 0.35
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 39.88 4.95 3.81 3.13 1.49 1.09
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 242.53 280.90 0.00 25.54 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.89 0.59 2.98 0.00 0.00 0.00 0.00 0.00 0.00 11.42
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.02 0.03 0.03 0.03 0.02 0.01 0.02 0.02 0.02 0.17
Long-Term Debt to Equity		 0.00 0.02 0.03 0.03 0.03 0.02 0.01 0.02 0.02 0.00 0.15
Financial Leverage		 0.00 0.02 0.01 0.01 0.03 0.02 0.02 0.02 0.02 0.02 0.08
Leverage Ratio		 0.00 1.22 1.22 1.40 2.01 1.41 1.28 1.65 1.54 1.26 1.20
Compound Leverage Factor		 0.00 1.22 1.22 1.97 3.70 -2.88 1.28 1.12 1.56 -1.29 1.20
Debt to Total Capital		 0.00% 2.17% 2.56% 3.02% 3.13% 1.98% 1.27% 1.79% 1.69% 1.78% 14.46%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.78% 1.53%
Long-Term Debt to Total Capital		 0.00% 2.17% 2.56% 3.02% 3.13% 1.98% 1.27% 1.79% 1.69% 0.00% 12.93%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 31.78% 23.14% 17.37% 16.65% 8.73% 7.69%
Common Equity to Total Capital		 0.00% 97.83% 97.44% 96.98% 96.87% 66.24% 75.59% 80.85% 81.66% 89.49% 77.85%
Debt to EBITDA		 0.00 -0.01 -0.01 -0.01 -0.03 -0.07 -0.14 -0.04 -0.04 -0.03 -0.34
Net Debt to EBITDA		 0.00 0.39 0.40 0.35 1.12 3.56 11.23 2.04 2.29 1.98 2.14
Long-Term Debt to EBITDA		 0.00 -0.01 -0.01 -0.01 -0.03 -0.07 -0.14 -0.04 -0.04 0.00 -0.30
Debt to NOPAT		 0.00 -0.02 -0.02 -0.02 -0.04 -0.10 -0.09 -0.08 -0.10 -0.05 -0.83
Net Debt to NOPAT		 0.00 0.55 0.58 0.49 1.43 5.08 7.49 4.60 6.07 2.83 5.28
Long-Term Debt to NOPAT		 0.00 -0.02 -0.02 -0.02 -0.04 -0.10 -0.09 -0.08 -0.10 0.00 -0.75
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 16.95% 15.74% 11.16% 11.06% 20.03% 17.40%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 9.55 8.05 10 11 -3.97 -0.73 -4.78 -4.77 -3.34 -0.43 1.62
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.07 0.16 0.23 0.30 0.33 0.26
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 218.40 908.67 1,322.00 2,423.00 303.18 313.50
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 5.45 4.62 3.91 3.77 5.96 9.31 6.61 6.99 6.61 7.73
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.10 0.20 0.38 0.45 0.41 0.29
Increase / (Decrease) in Invested Capital		 -14 -9.76 -11 -11 3.77 0.51 4.70 2.70 3.22 0.65 -1.58
Enterprise Value (EV)		 0.00 2.83 2.03 10 12 22 6.74 7.56 7.60 3.85 2.73
Market Capitalization		 8.22 6.46 6.22 14 17 26 14 13 13 10 9.21
Book Value per Share		 $0.00 $0.91 $0.77 $0.63 $0.60 $0.63 $0.95 $0.72 $0.76 $0.77 $0.77
Tangible Book Value per Share		 $0.00 $0.91 $0.77 $0.63 $0.60 $0.63 $0.95 $0.72 $0.76 $0.77 $0.77
Total Capital		 0.00 5.45 4.62 3.91 3.77 5.96 9.31 6.61 6.99 6.61 7.73
Total Debt		 0.00 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 1.12
Total Long-Term Debt		 0.00 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.00 1.00
Net Debt		 0.00 -3.63 -4.19 -3.87 -4.70 -5.78 -9.48 -6.54 -7.06 -6.86 -7.07
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 2.35 0.42 0.27 0.41 0.33 0.10 0.04 -0.06 0.05 0.00 0.00
Net Nonoperating Obligations (NNO)		 0.00 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 1.12
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.46) ($0.15) ($0.14) ($0.09) ($0.07) ($0.02) ($0.25) ($0.02) $0.01 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 5.87M 6.01M 6.01M 6.12M 6.10M 6.90M 7.44M 7.66M 7.39M 7.80M
Adjusted Diluted Earnings per Share		 $0.00 ($0.46) ($0.15) ($0.14) ($0.09) ($0.07) ($0.02) ($0.25) ($0.02) $0.01 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 5.87M 6.01M 6.01M 6.12M 6.10M 6.90M 7.44M 7.66M 7.39M 7.80M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 5.87M 6.01M 6.04M 6.23M 7.44M 7.44M 7.54M 7.68M 7.80M 8.10M
Normalized Net Operating Profit after Tax (NOPAT)		 -4.95 -1.71 -0.47 -0.41 -0.21 -0.22 0.09 -2.07 -0.12 0.16 0.03
Normalized NOPAT Margin		 0.00% 0.00% 0.00% -929.09% -100.05% -53.25% 12.34% -310.99% -18.45% 27.22% 4.49%
Pre Tax Income Margin		 0.00% 0.00% 0.00% -1,865.91% -263.41% -76.07% -18.06% -301.81% -26.67% 38.89% 6.10%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Oxbridge Re’s latest quarter shows a sharp turnaround in profitability and cash generation, but the company is still operating with a very small revenue base and a balance sheet that relies heavily on financing. For Q1 2026, net income attributable to common shareholders was $22,000, a major improvement from the $118,000 common-shareholder profit in Q4 2025 and the $187.3 million loss reported in Q2 2025.

The strongest takeaway from the quarter was cash flow. Oxbridge Re generated $210,000 of operating cash flow in Q1 2026, up from $433,000 in Q4 2025 but far better than the negative operating cash flow seen earlier in 2025 and 2024. The company also raised $1.0 million of debt, which helped drive a $1.212 million increase in cash and equivalents during the quarter.

Revenue in Q1 2026 was $623,000, slightly above the $576,000 posted in Q4 2025. Premiums earned held steady at $555,000, while capital gains contributed $68,000. However, profitability remains thin because operating expenses were still high at $585,000, nearly matching revenue.

Looking back over the last year, the company’s results have been volatile. After a very weak first half of 2025, Oxbridge Re improved in the second half of the year and entered 2026 with positive quarterly earnings. Still, the business has not yet shown a consistent pattern of durable profitability.

The balance sheet also improved in some areas, with total assets rising to $8.74 million in Q1 2026 from $7.82 million in Q2 2025. At the same time, total liabilities declined to $2.12 million from $2.69 million, which suggests some cleanup on the liability side. Equity increased to $6.02 million, though retained earnings remain deeply negative at -$32.1 million.

  • Positive: Q1 2026 net income attributable to common shareholders turned positive at $22,000.
  • Positive: Operating cash flow was positive at $210,000, showing the business is still generating cash from operations.
  • Positive: Revenue edged higher to $623,000 from $576,000 in Q4 2025.
  • Positive: The company posted a $1.212 million increase in cash and equivalents in Q1 2026.
  • Positive: Total liabilities fell to $2.12 million from $2.69 million in Q2 2025.
  • Neutral: Premiums earned stayed flat at $555,000, indicating stable core insurance revenue but limited growth.
  • Neutral: Capital gains on investments were positive, but at $68,000 they were not a major earnings driver.
  • Neutral: Basic and diluted EPS were reported at $0.00, reflecting very small absolute earnings.
  • Negative: Operating expenses remained high at $585,000, leaving little room for profit.
  • Negative: Retained earnings are still deeply negative at -$32.1 million, showing a long history of losses.

Overall, Oxbridge Re looks like a micro-cap insurer/reinsurer that has recently stabilized after a very volatile stretch. The latest quarter was encouraging, but investors should still view the stock as speculative until the company can show multiple consecutive quarters of consistent earnings and cash flow.

07/21/26 05:41 AM ETAI Generated. May Contain Errors.

Oxbridge Re Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Oxbridge Re's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Oxbridge Re's net income appears to be on an upward trend, with a most recent value of -$2.08 million in 2025, falling from $4 million in 2014. The previous period was -$2.59 million in 2024.

Over the last 10 years, Oxbridge Re's total revenue changed from $5.56 million in 2014 to $2.58 million in 2025, a change of -53.6%.

Oxbridge Re's total liabilities were at $1.56 million at the end of 2025, a 3.9% decrease from 2024, and a 88.0% decrease since 2014.

In the past 10 years, Oxbridge Re's cash and equivalents has ranged from $268 thousand in 2025 to $12.24 million in 2016, and is currently $268 thousand as of their latest financial filing in 2025.

Over the last 10 years, Oxbridge Re's book value per share changed from 6.12 in 2014 to 0.77 in 2025, a change of -87.4%.


Related Companies

Financial statements for NASDAQ:OXBRW last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel